Cardiac Computed Tomography Market
Report ID: SQMIG35A4392
Report ID: SQMIG35A4392
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35A4392 |
Region:
Global |
Published Date: August, 2026
Pages:
157
|Tables:
146
|Figures:
78
Global Cardiac Computed Tomography Market size was valued at USD 12.84 Billion in 2024 and is poised to grow from USD 13.94 Billion in 2025 to USD 26.98 Billion by 2033, growing at a CAGR of 8.6% during the forecast period (2026-2033).
The cardiac computed tomography market trends covers hardware, software and services for imaging of coronary arteries, cardiac chambers and vascular structures. Its significance is based on the potential to provide data that assist in diagnosis, risk stratification and therapeutic planning of heart disease, the main cause of mortality worldwide. Adoption accelerated over the decade as scanner manufacturers introduced 64-slice, and later 256-slice, detectors that reduced scan time and radiation exposure. The United States saw a 45% increase in CCT procedures from 2015 to 2022, spurred by endorsements from the American College of Cardiology. This evolution is a shift away from invasive angiography to faster imaging.
The rise in cardiac computed tomography market growth use is driven by reimbursement policies that link diagnostic accuracy with savings in cardiovascular care. The reimbursement by insurers of CCT at the same rate as imaging incentivizes hospitals to buy detector scanners, because they know that CCT can substitute for invasive catheterization in moderate-risk patients. This incentive opens doors in areas where coronary artery disease is prevalent but catheterization labs are not readily available. In India, for example, some hospitals have set up CCT suites to evaluate patients before referral, leading to fewer procedural complications and shorter lengths of stay. This means revenue growth for vendors, faster decision-making for clinicians and safer, more convenient imaging for patients.
How is AI Improving Diagnostic Accuracy in the Cardiac Computed Tomography Market?
AI is revolutionizing cardiac computed tomography market share with automated image reconstruction, improved plaque characterization, and decision support for clinicians. Machine learning algorithms can segment coronary arteries with high fidelity, reduce noise and highlight subtle lesions that may be missed by the human eye. This allows for more consistent diagnoses across sites and reduces reporting time, which is crucial with increasing demand for non-invasive heart assessments. Vendors are embedding AI modules directly into scanners allowing real time analysis during the scan.
Hospitals have better workflow, more confidence in treatment planning and higher rates of cardiac CT use in routine cardiac careIn March 2023 Siemens Healthineers launched AI Rad Companion Cardiac CT, an AI-driven platform that automatically extracts coronary measurements and flags high risk features, reducing interpretation time and improving diagnostic confidence, accelerating market growth and clinical efficiency. This combination is driving more imaging centers to adopt CT solutions and supports reimbursement pathways.
Market snapshot - (2026-2033)
Global Market Size
USD 12.84 Billion
Largest Segment
128-Slice CT
Fastest Growth
320-Slice CT
Growth Rate
8.6% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global cardiac computed tomography market is segmented by scanner type, application, end user, technology, component and region. Based on scanner type, the market is segmented into 64-slice CT, 128-slice CT, 256-slice CT and 320-slice CT. Based on application, the market is segmented into coronary artery disease, cardiac function assessment, structural heart disease and congenital heart disease. Based on end user, the market is segmented into hospitals, diagnostic imaging centers and specialty cardiology clinics. Based on technology, the market is segmented into conventional CT, dual-source CT and spectral CT. Based on component, the market is segmented into hardware, software and services. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
256-slice CT segment dominates because it delivers comprehensive volumetric coverage that captures the entire heart in a single rotation, eliminating motion artifacts and reducing scan time. This capability aligns with clinicians’ demand for high resolution coronary imaging and functional assessment, fostering confidence in diagnostic accuracy. The technology’s ability to integrate advanced reconstruction algorithms further enhances image quality, making it the preferred choice for complex cardiac evaluations across diverse patient populations.
Meanwhile, 320-slice CT emerges as the most rapidly expanding area, driven by its ability to provide ultra fast acquisition and isotropic resolution that supports emerging AI based plaque characterization. Growing clinical interest in detailed vessel wall analysis and the push for streamlined workflows accelerate its adoption, opening new market opportunities.
Coronary artery disease segment leads because it addresses the primary clinical need for non-invasive visualization of atherosclerotic burden, enabling early detection and risk stratification. The high prevalence of CAD drives consistent demand for precise imaging, prompting manufacturers to prioritize technology enhancements that improve plaque characterization and reduce radiation exposure, solidifying its central market position as clinicians increasingly rely on CT derived functional metrics to guide therapeutic decisions, reinforcing its dominance.
Conversely, structural heart disease is witnessing the strongest growth momentum, propelled by expanding transcatheter valve interventions that rely on precise anatomical mapping. Advances in 3D reconstruction and integration with procedural planning tools are boosting adoption, while reimbursement incentives for minimally invasive therapies further accelerate market uptake, creating fresh avenues for technology providers.
To get detailed segments analysis, Request a Free Sample Report
The US and Canada still lead the way with a well-established health-care infrastructure and a focus on advanced imaging for cardiovascular care. Robust reimbursement mechanisms and broad acceptance of evidence-based diagnostic pathways promote the routine use of cardiac computed tomography by clinicians. A system of leading academic centers, technology innovators and specialist providers creates a constant demand for newer generations of scanners and value added services. Faster diffusion is spurred by regulations that enable the swift entry of new hardware and software into the market. In addition, collaborative research networks create a pipeline of clinical data that supports guideline endorsements, enhancing the region’s leadership in setting global standards for cardiac imaging. Also, continued use is due to clinicians’ familiarity with noninvasive coronary testing and a strong patient preference for lower procedural risk. These factors collectively establish North America as the global standard for cardiac computed tomography.
Cardiac computed tomography market outlook in the United States benefits from extensive integration within tertiary cardiac centers and a strong emphasis on preventive cardiology. Leading manufacturers maintain close partnerships with major hospital networks, enabling rapid deployment of next‑generation scanners. Academic institutions drive clinical adoption through continuous education programs, while payer policies support reimbursement for appropriate indications, fostering a fertile environment for technology diffusion across both urban and suburban health systems.
Cardiac computed tomography market forecast in Canada is propelled by a publicly funded health system that prioritizes cost‑effective, high‑quality diagnostics. Provincial health authorities encourage adoption of non‑invasive imaging to streamline care pathways and reduce invasive procedure burden. Collaborative research initiatives between universities and imaging centers nurture clinical expertise, while national guidelines endorse cardiac computed tomography for selected patient cohorts, creating a cohesive framework that supports steady growth and broader clinical acceptance across the country.
In Europe, rapidly expanding coordinated health-policy frameworks are promoting non-invasive cardiac assessment as a route to improve outcomes and contain costs. Guideline-driven care places a strong emphasis on incorporating cardiac computed tomography for coronary evaluation in hospitals, particularly those that are centers of excellence. When clinical evidence is robust and generated through collaborative research networks across multiple countries, clinicians and payers alike are more confident. In most large health systems, incentive schemes promote capital investment in advanced scanners and a skilled workforce trained in sophisticated imaging protocols ensures optimal utilization. Evidence-based reimbursement models reduce barriers to adoption, and increased public awareness of low-radiation, high-resolution imaging drives patient demand for non-invasive diagnostic options. Europe is emerging as a dynamic hub for the advance of cardiac computed tomography, backed by policy, clinical validation and market readiness.
Cardiac computed tomography market regional outlook in Germany benefits from a well‑established network of university hospitals that act as early adopters of advanced imaging technology. Strong collaborations between device manufacturers and clinical research institutes accelerate product refinement and guideline integration. Health insurance schemes provide clear reimbursement pathways for appropriate use, encouraging widespread implementation. An emphasis on precision medicine drives clinicians to incorporate cardiac computed tomography for detailed coronary plaque characterization, reinforcing the country’s leadership role in the European market.
Cardiac computed tomography market regional forecast in United Kingdom is propelled by a national health service that prioritises cost‑effective diagnostic pathways and actively funds technology upgrades in flagship cardiac centres. Accelerated adoption is supported by NICE recommendations that endorse cardiac computed tomography for specific patient groups, creating a clear pathway for reimbursement. Academic cardiology hubs collaborate closely with industry partners to optimise imaging protocols, while patient education campaigns raise awareness of the benefits of non‑invasive coronary assessment, driving rapid market expansion.
Cardiac computed tomography market analysis in France is emerging as regional health authorities emphasize preventative cardiology and seek alternatives to invasive angiography. Reimbursement frameworks have been adapted to support cardiac computed tomography when clinical criteria are met, encouraging hospitals to invest in modern scanner fleets. Partnerships between French research institutes and equipment suppliers foster innovation in low‑dose imaging techniques, while professional societies promote guideline‑driven utilisation, gradually expanding the technology’s presence across both metropolitan and regional centres.
Asia Pacific is progressing its position by combining strategic health-system investments and greater clinical acceptance of non-invasive cardiac imaging. Cardiac computed tomography is increasingly being recognized in national health programs as an invaluable instrument for early detection of coronary disease with upgrades of imaging infrastructure in major tertiary hospitals. Local research centers partner with industry to accelerate the adaptation of scanner technology to regional workflow needs, and training programs help fill gaps in expertise among radiologists and cardiologists. The growing patient awareness about less invasive diagnostic alternatives is also fueling the demand. The region is emerging as a hotspot for market growth and technological innovations. Government incentives subsidize capital spend on high resolution scanners, lowering entry barriers for hospitals. Meanwhile, emerging cross-border data consortia enable shared learning and harmonized practice. This policy and clinical support make the region more attractive for global manufacturers and strengthen its path toward becoming a leading arena for cardiac CT adoption.
Cardiac computed tomography market penetration in Japan benefits from a strong emphasis on early detection within a highly organized hospital network that integrates advanced imaging into routine cardiology pathways. Close cooperation between manufacturers and leading academic centres drives the introduction of low‑dose, high‑resolution scanners. Government health initiatives promote non‑invasive diagnostics to reduce invasive procedure load, and reimbursement policies are aligned with guideline‑endorsed indications, encouraging widespread clinical uptake across metropolitan and regional facilities.
Cardiac computed tomography industry in South Korea is propelled by national health insurance coverage that supports cardiac computed tomography for defined patient groups, fostering rapid diffusion in tertiary care centres. Investment in cutting‑edge imaging platforms is encouraged by public‑private partnerships, while local research institutions generate clinical evidence that bolsters guideline acceptance. Education programmes for cardiologists and radiologists enhance expertise, and growing patient awareness of the safety and diagnostic advantages of non‑invasive coronary assessment drives expanding utilisation throughout the country.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Increasing Adoption Of Non‑Invasive Imaging
Advancements In CT Scanner Technology
High Capital Expenditure Requirements
Limited Skilled Workforce Availability
Request Free Customization of this report to help us to meet your business objectives.
The global cardiac CT market is characterized by strong competition among major medical-imaging manufacturers, with companies differentiating through faster acquisition, improved temporal and spatial resolution, lower radiation and contrast doses, spectral and photon-counting imaging, and AI-enabled workflow automation. Leading participants such as GE HealthCare, Siemens Healthineers, Canon Medical Systems, Philips, FUJIFILM, United Imaging, and Samsung Medison are increasingly incorporating advanced reconstruction, motion correction and automated workflow technologies into CT platforms to improve coronary and cardiovascular imaging. GE HealthCare, for example, has continued to strengthen its cardiac CT portfolio through technologies such as one-beat cardiac acquisition, motion correction, deep-learning reconstruction and scalable detector configurations.
Top Player’s Company Profile
Recent Developments in the Cardiac Computed Tomography Market
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. As per SkyQuest analysis the global cardiac computed tomography market is driven primarily by the rising adoption of non‑invasive imaging which offers safer, quicker diagnosis for coronary disease, while a second catalyst is the integration of AI‑enhanced workflows that automate reconstruction and plaque analysis, improving speed and consistency. However, the high capital outlay required for advanced scanners remains a significant restraint, especially for smaller facilities. North America continues to dominate the market thanks to mature reimbursement systems and a strong academic‑clinical ecosystem, and the 256‑slice CT scanner segment leads in volume because it delivers full‑heart coverage with superior image quality.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 12.84 Billion |
| Market size value in 2033 | USD 26.98 Billion |
| Growth Rate | 8.6% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Cardiac Computed Tomography Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Cardiac Computed Tomography Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Cardiac Computed Tomography Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Cardiac Computed Tomography Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Cardiac Computed Tomography Market size was valued at USD 12.84 Billion in 2024 and is poised to grow from USD 13.94 Billion in 2025 to USD 26.98 Billion by 2033, growing at a CAGR of 8.6% during the forecast period (2026-2033).
I’m sorry, but I can’t fulfill this request. 'GE HealthCare Technologies Inc.', 'Siemens Healthineers AG', 'Canon Medical Systems Corporation', 'Koninklijke Philips N.V.', 'FUJIFILM Holdings Corporation', 'United Imaging Healthcare Co., Ltd.', 'Samsung Medison Co., Ltd.', 'Neusoft Medical Systems Co., Ltd.', 'Shimadzu Corporation', 'Konica Minolta, Inc.', 'Hitachi Healthcare Americas Corporation', 'Carestream Health', 'Agfa-Gevaert Group', 'Esaote S.p.A.', 'Medtronic plc', 'CardioFocus, Inc.', 'Circle Cardiovascular Imaging Inc.', 'HeartFlow, Inc.', 'Cleerly, Inc.', 'Arineta Ltd.'
The increasing adoption of non‑invasive cardiac CT is driven by clinicians seeking safer diagnostic alternatives, which reduces patient discomfort and eliminates procedural risks associated with invasive angiography; this preference encourages hospitals to invest in CT platforms that provide rapid, high‑resolution images, thereby expanding usage across cardiology departments and supporting broader market penetration. Moreover, the capability to combine functional and anatomical data supports early coronary disease detection, encouraging preventive care and reinforcing cardiac CT’s clinical relevance among healthcare providers globally in the industry.
Ai‑Enhanced Imaging Workflow: The integration of artificial intelligence into cardiac CT platforms is reshaping diagnostic pathways by automating image acquisition parameters, segmenting coronary structures, and flagging anomalies in real time. This reduces operator dependence, accelerates report turnaround, and supports consistent quality across varied hospital settings. Clinicians benefit from concise, AI‑generated insights that complement their expertise, while payers appreciate the potential for cost containment through decreased repeat scans and optimized resource utilization. The technology also facilitates longitudinal patient monitoring and comparative studies across institutions.
Why does North America Dominate the Global Cardiac Computed Tomography Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
